I
Power Law company profile
Imago BioSciences
Biotech & Life Sciences · San Carlos, United States · Founded 2012 · IPO 2021 Unicorn
Valuation
$1.04B
Market cap · 2026
Patent intelligence
$32M patent portfolio · 14 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$32M
3.1% of market cap · 16.4× smaller than top peer ChemoCentryx ($524M)
14 active patent families
Where Imago BioSciences innovates
DiseaseMolecular biologyCancer researchKDM1AGlobin gene expression
Above peer median on Legal, Strategic, Market, Technology
Quality vs same-sector peers
Imago BioSciences on the five Patsnap quality dimensions
Imago BioSciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Imago BioSciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Imago BioSciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Imago BioSciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.